Reason for request
Inscription
Mise à disposition d'un médicament similaire à TRAVATAN 40 µg/ml, collyre en solution mais formulé sans conservateur.
Clinical Benefit
| Substantial |
Le service médical rendu par VIZITRAV 40 µg/ml, collyre en solution est important dans les indications de l’AMM. |
Clinical Added Value
| no clinical added value |
VIZITRAV 40 µg/ml, collyre en solution n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à TRAVATAN 40 µg/ml, collyre en solution. |
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
6UbwB2EqmJwCHdfn
